Pegylated Irinotecan
I 225612
Phase 2 small_molecule completed
Quick answer
Pegylated Irinotecan for Recurrent Small Cell Lung Carcinoma is a Phase 2 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Recurrent Small Cell Lung Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed